Alexander Maur
Kanzlei am Ärztehaus Frehse Mack Vogelsang, Cologne (Bayenthal), GERMANY
Lawyer and Partner
More information please click here.
Dr. Ulrich Vogel
Boehringer Ingelheim International GmbH, Ingelheim, GERMANY
Head Strategic Data Analysis, Global Pharmacovigilance Member CIOMS Working Group VIII, Practical Aspects of Signal Detection in Pharmacovigilance
Wei Wannhoff
Merck Healthcare KGaA, Darmstadt, GERMANY
Safety Data Analyst; After her studies in bioinformatics in Germany she was able to collect hands on experience in data management and SAE management in clinical research. She is an experienced professional with a strong focus on pharmacovigilance and drug safety management with 15 years of industry experience. Her career journey reflects a commitment to excellence, innovation, and compliance within the realm of drug safety and safety data retrieval. With a comprehensive understanding of regulatory requirements and a proven track record in data analysis, software tool development, and compliance management, Wei has demonstrated expertise in leading cross-functional teams and driving process improvements. She owns the important role as AI champion to lead the company-internal AI use cases in drug safety field.
20/01/2025
20/01/2025
09:00-17:00 CET
You may join the session 30 minutes before it begins.
online
online
Event - 1,290 € plus tax
The fee includes high-quality course material for download, a certificate of participation, access to our Learning Space and technical support, including a test meeting.
Event - 1,290 € plus tax
The fee includes high-quality course material for download, a certificate of participation, access to our Learning Space and technical support, including a test meeting.
Nadja Wolff
Conference Manager
+49 6221 500-696
n.wolff@forum-institut.de
Explore the transformative potential of artificial intelligence in pharmacovigilance. This course provides an in-depth understanding of AI technologies, regulatory requirements, and practical applications in drug safety. Through expert insights and hands-on workshops, you'll learn how to leverage AI to enhance your pharmacovigilance processes. Register now to future-proof your PV operations.
Artificial intelligence (AI) is recognised by many business experts as the next key innovation, a game changer poised to transform the entire work landscape, including that of the pharmaceutical industry. The potential applications in pharmacovigilance - from streamlined and automated ICSR management to automatic additional monitoring and signal detection, from summarising relevant information and aiding benefit-risk evaluation, to automatic report generation - are vast. This course will bring you up to date with emerging opportunities and challenges.
Following the passing of the EU AI Act in 2023, additional guidelines for the pharmaceutical industry are expected in the coming years. Our industry and legal experts will outline what these are likely to entail.
This online course about AI in pharmacovigilance will cover:
08:45
09:00 Welcome and introduction
09:15
Wei Wannhoff
09:45
Alexander Maur
10:45 Coffee break
11:00
Dr Ulrich Vogel
11:30
Wei Wannhoff
12:15 Lunch
13:15
Dr Ulrich Vogel
14:00
Wei Wannhoff
14:45 Coffee break
15:00
Dr Ulrich Vogel
15:45
Wei Wannhoff, Alexander Maur
16:30
All speakers
17:00 Course ends
of 5 stars of all ratings from 2023
of 5 stars on Trustpilot = good
This online conference addresses the digitalisation of labelling, the transformational potential of emerging technologie...
- GVP Module XVI Risk minimisation measures (Rev 3) came into force - Do you already have a good understanding of PSUR a...
FDA inspection readiness: Gain the knowledge and skills necessary to manage future FDA inspections with confidence and e...
Non-clinical/clinical content in the dossier: Are you a beginner in the field and would like to feel confident working c...
CMC requirements in the US: After having attended the seminar you will feel secure writing and maintaining the quality d...
I was a great introduction into thetopic, explaining basic terminologyand modes of working of AI. Alsopractical examples were providedand existing commercializedsolutions. I liked the aspect of legalframework and ethics. The slidesare helpful to follow up certaintopics later.
Gives me an overview of thediff erent application of AI in PV.